CClinicalTrials.gg
CompletedNCT04967846Updated May 10, 2022

Social Media Effects on Mental Health

An observational study in Mental Health Issue, Mental Health Wellness 1 and Mental Health Wellness 2, sponsored by Yale-NUS College. Completed at 1 site in Singapore. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-10.

Sponsored by Yale-NUS College · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
608
Ages
21 Years and older
Sex
All
01

Study summary

In the last decade, research on social media and mental health has produced mixed results. Overall, the current findings suggest that the negative effects on mental health are exacerbated by longer and more frequent social media usage, whereas the positive effects are bolstered when social media is used to connect with other people.

With the largest number of global users, Facebook is the most frequently studied social media network. Over the past few years, the increasing concerns about the risks associated with Facebook have even translated to wider pop culture conversations, as exemplified by the 2020 documentary The Social Dilemma. In response, Facebook has rolled out a series of features supposed to mitigate these risks and encourage responsible social media usage. These features include activity trackers and reminders, unfollow and snooze buttons, and data sharing regulators. Currently, there is no research done to address whether (1) these features are used at all, and (2) whether they are successful in moderating the negative mental health consequences of Facebook usage.

This study seeks to address the gap in literature through a survey done on the crowdsourcing platform Amazon Mechanical Turk (MTurk).

02

Conditions studied

  • Mental Health Issue
  • Mental Health Wellness 1
  • Mental Health Wellness 2
  • Social Media Addiction
  • Internet Addiction

Keywords

  • Social Media
  • Facebook
  • Mental Health
  • Wellbeing
03

In context

Behavior, Addictive

540 studies on the registry are indexed under Behavior, Addictive; 134 are open to participants now.

This study's enrollment of 608 is above the median of 170 across 133 observational studies indexed under Behavior, Addictive.

Browse Behavior, Addictive studies →

Lead sponsor

Yale-NUS College is the lead sponsor of 29 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Recruiting a representative sample of 740 people on the crowdsourcing platform Amazon Mechanical Turk (MTurk).

Inclusion criteria

  • Healthy adult volunteers, aged 21 and above
  • English proficiency
  • Facebook users

Exclusion criteria

Exclusion Criteria

  • Participants below 21 years old
  • Non-Facebook users
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
608 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Mental Health Scores

    Depression, Anxiety, and Stress Scale (DASS-21), (measured on a 4 point scale: min = 0, max = 3; higher scores indicating higher depression, anxiety and/or stress).

    Time frame: Once during the survey.

07

Study locations

1 site
  • Yale NUS
    Singapore, Singapore
08

References and documents

Publications

  • Barsova T, Cheong ZG, Mak AR, Liu JC. Predicting Psychological Symptoms When Facebook's Digital Well-being Features Are Used: Cross-sectional Survey Study. JMIR Form Res. 2022 Aug 29;6(8):e39387. doi: 10.2196/39387. PubMed 36036971 ↗

Individual participant data

Plan to share: No — Yale-NUS College regulations do not allow the sharing of private participant information.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04967846
Lead sponsor
Yale-NUS College
Responsible party
Sponsor
First posted
Jul 20, 2021
Start date
Jun 13, 2021
Primary completion
Aug 24, 2021
Completion
Sep 19, 2021
Last update
May 10, 2022

Study contacts

Tamara Barsova
principal investigator · Yale-NUS College

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion